Department of Laboratory Medicine, University of Washington, Seattle, Washington.
Seattle Cancer Care Alliance, Seattle, Washington.
Cytometry B Clin Cytom. 2019 Jul;96(4):300-309. doi: 10.1002/cyto.b.21775. Epub 2019 Feb 25.
Abnormalities involving chromosome 7 are one of the most frequent chromosomal aberrations in myeloid neoplasms including myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) and are associated with an adverse prognosis. Immunophenotyping by flow cytometry provides data that can assist in the diagnosis and classification of myeloid neoplasms. The immunophenotypic features of myeloid neoplasms with monosomy 7 or del(7q) have not been previously described in a comprehensive fashion.
We retrospectively analyzed flow cytometric data of myeloid neoplasms with monosomy 7 or del(7q) and summarized associated immunophenotypic features.
Myeloid neoplasms with monosomy 7 typically demonstrate multiple immunophenotypic abnormalities on myeloid blasts and maturing myelomonocytic cells. Increased CD14 expression on maturing granulocytic cells was characteristically seen in myeloid neoplasms with monosomy 7. This abnormality was significantly more frequent in myeloid neoplasms with monosomy 7 than in those with del(7q) (92.9% vs. 8.2%, P < 0.0001). The presence of increased CD14 expression on maturing granulocytic cells could be seen in cases with monosomy 7 in the setting of a normal blast percentage and when minimal (<3) other immunophenotypic abnormalities were seen on myeloid populations.
Increased CD14 expression on maturing granulocytic cells can be helpful in identifying patients with myeloid neoplasms who have monosomy 7. © 2019 International Clinical Cytometry Society.
异常涉及 7 号染色体是最常见的染色体异常之一,包括骨髓增生异常综合征(MDS)和急性髓系白血病(AML),与不良预后相关。流式细胞术免疫表型分析提供的数据可以协助骨髓增生性肿瘤的诊断和分类。7 号染色体单体或 del(7q)的髓系肿瘤的免疫表型特征以前没有全面描述过。
我们回顾性分析了 7 号染色体单体或 del(7q)的髓系肿瘤的流式细胞术数据,并总结了相关的免疫表型特征。
7 号染色体单体的髓系肿瘤在髓系原始细胞和成熟髓单核细胞上通常表现出多种免疫表型异常。成熟粒细胞上 CD14 的表达增加在 7 号染色体单体的髓系肿瘤中特征性出现。这种异常在 7 号染色体单体的髓系肿瘤中明显比在 del(7q)的髓系肿瘤中更为常见(92.9% vs. 8.2%,P<0.0001)。在成熟粒细胞上 CD14 表达增加可见于 7 号染色体单体的病例中,当 blast 比例正常且髓系群体上只有少量(<3)其他免疫表型异常时。
成熟粒细胞上 CD14 表达增加有助于识别具有 7 号染色体单体的髓系肿瘤患者。